MoonLake Immunotherapeutics
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
MLTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- KY61559X1045
- LEI:
- Country:
- United States of America
- Address:
- DORFSTRASSE 29, 6300 ZUG
- Website:
- https://moonlaketx.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and immunologic diseases. The company leverages its proprietary Nanobody® technology to create innovative treatments for conditions with significant unmet medical needs. Its lead product candidate, Sonelokimab, is a Nanobody-based therapy in late-stage clinical development with a Phase 3 program targeting indications such as hidradenitis suppurativa and psoriatic arthritis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MoonLake Immunotherapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MoonLake Immunotherapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MoonLake Immunotherapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
